These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 21513739

  • 1. Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation.
    Shen C, He Y, Cheng K, Zhang D, Miao S, Zhang A, Meng F, Miao F, Zhang J.
    Immunol Lett; 2011 Aug 30; 138(2):144-55. PubMed ID: 21513739
    [Abstract] [Full Text] [Related]

  • 2. Antigen-specific killer polylactic-co-glycolic acid (PLGA) microspheres can prolong alloskin graft survival in a murine model.
    Wang W, Fang K, Wang X, Li M, Wu Y, Chen F, Shahzad KA, Gu N, Shen C.
    Immunol Invest; 2015 Aug 30; 44(4):385-99. PubMed ID: 25942349
    [Abstract] [Full Text] [Related]

  • 3. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG, Liu Z, Wu Y.
    Transpl Immunol; 2005 Oct 30; 15(1):9-16. PubMed ID: 16223668
    [Abstract] [Full Text] [Related]

  • 4. An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8+ T Cells.
    Wang W, Shahzad KA, Li M, Zhang A, Zhang L, Xu T, Wan X, Shen C.
    Front Immunol; 2017 Oct 30; 8():657. PubMed ID: 28649247
    [Abstract] [Full Text] [Related]

  • 5. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H, Hamano K, Fukumoto T, Wood KJ, Esato K.
    J Heart Lung Transplant; 1998 May 30; 17(5):460-9. PubMed ID: 9628564
    [Abstract] [Full Text] [Related]

  • 6. On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation.
    Shahzad KA, Wan X, Zhang L, Pei W, Zhang A, Younis M, Wang W, Shen C.
    Drug Deliv; 2018 Nov 30; 25(1):703-715. PubMed ID: 29508634
    [Abstract] [Full Text] [Related]

  • 7. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N, Motoyama K, Yu S, Shimizu Y, Margenthaler J, Tu F, Flye MW.
    Surgery; 2000 Aug 30; 128(2):206-12. PubMed ID: 10922993
    [Abstract] [Full Text] [Related]

  • 8. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U, Choksi S, Marcucci L, Korngold R.
    J Immunol; 1998 Jul 01; 161(1):421-9. PubMed ID: 9647252
    [Abstract] [Full Text] [Related]

  • 9. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J, Isobe M, Yamagami S, Mizuochi T, Tsuru T.
    Exp Eye Res; 1997 Jul 01; 65(1):89-98. PubMed ID: 9237869
    [Abstract] [Full Text] [Related]

  • 10. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
    Gordon EJ, Kelkar V.
    Xenotransplantation; 2009 Jul 01; 16(3):135-44. PubMed ID: 19566653
    [Abstract] [Full Text] [Related]

  • 11. Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells.
    Zhang HG, Su X, Liu D, Liu W, Yang P, Wang Z, Edwards CK, Bluethmann H, Mountz JD, Zhou T.
    J Immunol; 1999 Feb 01; 162(3):1423-30. PubMed ID: 9973398
    [Abstract] [Full Text] [Related]

  • 12. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y, Fujino M, Wang Q, Kimura H, Azuma M, Kubo M, Abe R, Li XK.
    Transplantation; 2007 Mar 27; 83(6):774-82. PubMed ID: 17414712
    [Abstract] [Full Text] [Related]

  • 13. Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections.
    Kusuhara M, Matsue H.
    Exp Dermatol; 2005 Apr 27; 14(4):273-80. PubMed ID: 15810885
    [Abstract] [Full Text] [Related]

  • 14. Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells.
    Schütz C, Fleck M, Mackensen A, Zoso A, Halbritter D, Schneck JP, Oelke M.
    Blood; 2008 Apr 01; 111(7):3546-52. PubMed ID: 18096763
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA, Landeros K, Kataoka M, Flye MW.
    Transpl Immunol; 2003 Apr 01; 11(1):23-9. PubMed ID: 12727472
    [Abstract] [Full Text] [Related]

  • 16. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, Okumura K, Yagita H, Kawai K.
    Int Immunol; 2008 Oct 01; 20(10):1343-9. PubMed ID: 18697765
    [Abstract] [Full Text] [Related]

  • 17. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y, Habran C, Buonocore S, Flamand V, Barvais L, Goldman M, Braun MY.
    Transplantation; 2006 Aug 27; 82(4):582-91. PubMed ID: 16958183
    [Abstract] [Full Text] [Related]

  • 18. A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo.
    Wang W, Fang K, Li MC, Chang D, Shahzad KA, Xu T, Zhang L, Gu N, Shen CL.
    Oncotarget; 2016 Mar 15; 7(11):12176-90. PubMed ID: 26910923
    [Abstract] [Full Text] [Related]

  • 19. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ, Blazar BR, Adeyi OA, Strom TB, Noelle RJ.
    Transplantation; 2003 Nov 15; 76(9):1375-9. PubMed ID: 14627918
    [Abstract] [Full Text] [Related]

  • 20. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K, Yung-Yun K, Omoto K, Umesue M, Murakami Y, Matsuzaki G, Nomoto K.
    Transplantation; 1995 Feb 15; 59(3):395-401. PubMed ID: 7871570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.